PharmGen Science, Inc.
KRX:004720.KS
4800 (KRW) • At close September 13, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||||||
| Nettowinst
| 5,727.239 | 89,960.3 | 41,949.485 | 11,209.29 | 404.179 | 3,892.561 | 6,079.298 | 4,502.012 | 2,132.505 | -4,645.206 | -3,859.727 | -5,277.688 | -8,689.834 | -2,765.635 | -1,946.753 | -11,315.404 | -221.835 |
| Afschrijvingen & Amortisatie
| 4,246.727 | 3,371.13 | 3,141.936 | 2,962.808 | 2,322.089 | 1,226.573 | 1,130.171 | 758.563 | 821.318 | 914.423 | 1,040.875 | 1,048.091 | 1,096.393 | 1,029.888 | 2,898.361 | 5,058.273 | 4,679.947 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | -47,417.872 | -8,392.402 | 0 | 1,594.354 | 235.517 | 918.269 | 0 | 0 | 0 | 0 | 0 | 0 | 1,734.269 | 3,879.255 | 1,556.405 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 4,359.33 | 1,671.318 | 0 | 366.637 | 599.674 | 452.631 | 0 | 0 | 0 | 0 | 0 | 0 | 30.62 | 167.625 | 140.07 |
| Verandering in Werkkapitaal
| -6,533.684 | -12,802.198 | 4,102.017 | -4,949.875 | -808.999 | -2,957.405 | -6,155.936 | 921.078 | 43.763 | 402.267 | -3,302.569 | -2,326.265 | 4,320.359 | -2,938.22 | -18,440.522 | 3,217.495 | -12,199.65 |
| Vorderingen
| -7,554.804 | -7,882.743 | 1,452.339 | -3,344.752 | -1,252.976 | -31.473 | -4,099.865 | 2,840.147 | -664.625 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 186.906 | -5,675.484 | 1,194.94 | -2,639.483 | -1,795.407 | -67.489 | 900.409 | -4,113.756 | 1,269.098 | -2,197.902 | -2,080.714 | 311.991 | 3,295.852 | -2,290.212 | 231.251 | 2,923.172 | -2,903.482 |
| Crediteuren
| -70.565 | 433.754 | 24.389 | 398.269 | 2,231.673 | -2,084.434 | -42.784 | 929.49 | -1,094.452 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 904.779 | 322.275 | 1,430.349 | 636.091 | 7.711 | -2,889.916 | -7,056.345 | 5,034.834 | -1,225.335 | 2,600.169 | -1,221.855 | -2,638.256 | 1,024.507 | -648.008 | -18,671.773 | 294.323 | -9,296.168 |
| Overige Niet-Contante Posten
| 1,998.66 | -81,815.409 | 1,649.197 | 174.473 | 606.127 | 92.862 | -50.961 | 202.103 | 623.987 | 1,311.622 | 1,916.565 | 2,580.225 | 6,166.362 | 5,302.458 | 1,021.317 | 2,816.338 | 511.46 |
| Kasstroom uit Operationele Activiteiten
| 5,438.941 | -1,286.177 | 7,784.093 | 2,675.612 | 2,523.396 | 4,215.582 | 1,837.763 | 7,754.656 | 3,621.573 | -2,016.894 | -4,204.856 | -3,975.637 | 2,893.28 | 628.491 | -14,702.708 | 3,823.582 | -5,533.603 |
| Investeringsactiviteiten: | |||||||||||||||||
| Investeringen in Materiële Vaste Activa
| -3,291.706 | -11,956.258 | -34,010.44 | -5,463.384 | -6,782.895 | -977.617 | -1,707.721 | -3,434.982 | -788.991 | -411.008 | -274.561 | -1,272.068 | -644.97 | -402.99 | -637.277 | -1,610.723 | -4,032.68 |
| Netto Overnames
| 80 | 190.253 | -3,000 | -550 | -23,721.776 | -2,000 | 181.801 | -30.954 | -16.398 | 0.001 | 44.998 | -232.266 | 2,380.7 | 15.221 | 3,078.46 | -6,091.34 | 1,274.445 |
| Aankoop van Beleggingen
| -1,500 | -3,500 | -3,213.887 | -4,500 | -22,083.096 | -21,759.644 | -16,015.719 | -23,864.644 | -5,332.956 | -6,177.297 | -1,175 | -483.064 | -769.038 | -3,049.867 | -29,257.198 | -70,322.29 | -24,163.119 |
| Verkoop/verval van Beleggingen
| 7,990.419 | 2 | 4,501 | 4,500 | 41,521.341 | 15,200 | 15,794.463 | 11,677.392 | 2,082 | 4,802.061 | 71 | 3,718.287 | 1,845.5 | 4,209.812 | 26,610.236 | 72,913.066 | 19,155.866 |
| Overige Investeringsactiviteiten
| -18.674 | -20.38 | 5,337.882 | -1,707.283 | 111.463 | 254.197 | -257.522 | -170.847 | 173.125 | -16.279 | 889.881 | -404.945 | 469.487 | -1.143 | -93.188 | -166.528 | -53.915 |
| Kasstroom uit Investeringsactiviteiten
| 3,260.04 | -15,284.385 | -30,385.446 | -7,720.668 | -10,954.963 | -9,283.064 | -2,004.699 | -15,824.035 | -3,883.22 | -1,802.522 | -443.682 | 1,325.944 | 3,281.679 | 771.033 | -298.967 | -5,277.815 | -7,819.403 |
| Financieringsactiviteiten: | |||||||||||||||||
| Schuldaflossingen
| -9,100 | -32,638.058 | -19,750 | -18.823 | -16,001.144 | -23.1 | -166.131 | -257.396 | -3,011.195 | -2,324.545 | -2,640.536 | -8,432.782 | -19,856.74 | -3,033.465 | -53,957.694 | -35,929.408 | -24,200.239 |
| Uitgifte van Gewone Aandelen
| -12.407 | -5.767 | -4.068 | 0 | 0 | 2,237.766 | 0 | 0 | 0.002 | 990.558 | 1,393.851 | 11,522.633 | 2,795.26 | 0 | 13,493.735 | 100 | 1,025.14 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.928 | 0 | 0 | 0 | 0 | 0 | 0 | -983.168 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 17,964.365 | 34,912.859 | 50,094.523 | 19,586.518 | 13,415.108 | 20,083.5 | 83.238 | 10,186.66 | 4,286.899 | 13,828.728 | 682 | 3,407.6 | 12,545.63 | 1,530 | 56,530.576 | 36,957.445 | 69,812.64 |
| Kasstroom uit Financieringsactiviteiten
| 8,851.958 | 2,269.033 | 30,340.455 | 19,567.694 | -2,586.036 | 22,298.167 | -82.893 | 9,929.264 | 1,275.706 | 5,563.449 | -564.685 | 6,497.451 | -4,515.85 | -1,503.465 | 16,066.617 | 1,128.037 | 10,622.133 |
| Overige Informatie: | |||||||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | -1,692.837 | 0 | 0 |
| Netto Kasstroomverandering
| 17,550.939 | -14,301.53 | 7,739.102 | 14,522.638 | -11,017.603 | 17,230.685 | -249.828 | 1,859.885 | 1,014.059 | 1,744.033 | -5,213.223 | 3,847.758 | 1,659.109 | -103.941 | -627.895 | -326.196 | -2,730.873 |
| Kaspositie aan het Einde van de Periode
| 36,905.532 | 19,354.593 | 33,656.122 | 25,917.02 | 11,394.382 | 22,411.985 | 5,181.301 | 5,431.129 | 3,571.243 | 2,557.184 | 813.151 | 6,026.374 | 2,178.616 | 518.202 | 622.143 | 1,250.038 | 1,576.234 |